Author:
Malleo Giuseppe,Maggino Laura,Ferrone Cristina R.,Marchegiani Giovanni,Luchini Claudio,Mino-Kenudson Mari,Paiella Salvatore,Qadan Motaz,Scarpa Aldo,Lillemoe Keith D.,Bassi Claudio,Fernàndez-del Castillo Carlos,Salvia Roberto
Funder
Associazione Italiana per la Ricerca sul Cancro
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Allen PJ, Kuk D, Castillo CF, et al. Multi-institutional validation study of the American Joint Commission on Cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg. 2017;265:185–91.
2. Kamarajah SK, Burns WR, Frankel TL, et al. Validation of the American Joint Commission on Cancer (AJCC) 8th-edition staging system for patients with pancreatic adenocarcinoma: a surveillance, epidemiology and end results (SEER) analysis. Ann Surg Oncol. 2017;24:2023–30.
3. van Roessel S, Kasumova GG, Verheij J, et al. International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer. JAMA Surg. 2018;153:e183617.
4. Schlitter AM, Jesinghaus M, Jäger C, et al. pT but not pN stage of the 8th TNM classification significantly improves prognostication in pancreatic ductal adenocarcinoma. Eur J Cancer. 2017;84:121–9.
5. Tempero MA, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pancreatic Adenocarcinoma V.1.2020. © 2020 National Comprehensive Cancer Network, Inc. Available at https://www.nccn.org/. Accessed 15 Apr 2020.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献